{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:14:49Z","timestamp":1774437289007,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1136\/ard.2007.071654","type":"journal-article","created":{"date-parts":[[2007,7,21]],"date-time":"2007-07-21T00:34:01Z","timestamp":1184978041000},"page":"542-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Do all anti-citrullinated protein\/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein\/peptide antibody tests in patients with and without rheumatoid arthritis"],"prefix":"10.1016","volume":"67","author":[{"given":"B","family":"Vander Cruyssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Van Praet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Deforce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Elewaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Serre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.071654_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"10.1136\/ard.2007.071654_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.071654_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.autrev.2005.04.018","article-title":"Anti-citrullinated protein\/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor","volume":"4","author":"Vander Cruyssen","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2007.071654_bib4","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin","volume":"166","author":"Masson-Bessi\u00e8re","year":"2001","journal-title":"J Immunol"},{"key":"10.1136\/ard.2007.071654_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2249.2004.02708.x","article-title":"IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin","volume":"139","author":"Chapuy-Regaud","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2007.071654_bib6","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar2011","article-title":"Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays","volume":"8","author":"Vander Cruyssen","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"S1","key":"10.1136\/ard.2007.071654_bib7","first-page":"A30","article-title":"Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for the diagnosis of rheumatoid arthritis","volume":"4","author":"Nogueira","year":"2002","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2007.071654_bib8","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ard.2004.029389","article-title":"Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis","volume":"64","author":"Nielen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.071654_bib9","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2008","article-title":"Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis","volume":"8","author":"Dejaco","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2007.071654_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","article-title":"Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis","volume":"53","author":"Coenen","year":"2007","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2007.071654_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686081","article-title":"Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome","volume":"32","author":"Wu","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1136\/ard.2007.071654_bib12","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De Rycke","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.071654_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.2004.022111","article-title":"Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus","volume":"64","author":"Hoffman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.071654_bib14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2004.032177","article-title":"Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis","volume":"64","author":"Vander Cruyssen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.071654_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2006.058933","article-title":"Anti-CCP2 positivity in non-RA disease samples: citrulline-dependent or not?","volume":"66","author":"Vannini","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.071654_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cccn.2004.11.025","article-title":"Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients","volume":"354","author":"Garcia-Berrocal","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1136\/ard.2007.071654_bib17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1515\/CCLM.2005.214","article-title":"Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis","volume":"43","author":"Fernandez-Suarez","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1136\/ard.2007.071654_bib18","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.071654_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/keh686","article-title":"The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis","volume":"44","author":"Korendowych","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.071654_bib20","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.071654_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.60.1.67","article-title":"Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"60","author":"Mediwake","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.071654_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7705\/biomedica.v24i2.1260","article-title":"[Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1]","volume":"24","author":"Correa","year":"2004","journal-title":"Biomedica"},{"key":"10.1136\/ard.2007.071654_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.071654_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10067-006-0313-3","article-title":"Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis","volume":"26","author":"Ingegnoli","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2007.071654_bib25","article-title":"In pursuit of B-cell synovial autoantigens in rheumatoid arthritis: confirmation of citrullinated fibrinogen, detection of vimentin and introducing carbonic anhydrase as a possible new synovial autoantigen","author":"Tilleman","year":"2007","journal-title":"Proteomics"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724218525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.071654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T15:40:28Z","timestamp":1736091628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724218525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0003496724218525"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.071654","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do all anti-citrullinated protein\/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein\/peptide antibody tests in patients with and without rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.071654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}